Literature DB >> 22232551

Caenorhabditis elegans RNA-processing protein TDP-1 regulates protein homeostasis and life span.

Tao Zhang1, Ho-Yon Hwang, Haiping Hao, Conover Talbot, Jiou Wang.   

Abstract

Transactive response DNA-binding protein (TARDBP/TDP-43), a heterogeneous nuclear ribonucleoprotein (hnRNP) with diverse activities, is a common denominator in several neurodegenerative disorders, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Orthologs of TDP-43 exist in animals ranging from mammals to invertebrates. Here, we systematically studied mutant Caenorhabditis elegans lacking the nematode TDP-43 ortholog, TDP-1. Heterologous expression of human TDP-43 rescued the defects in C. elegans lacking TDP-1, suggesting their functions are conserved. Although the tdp-1 mutants exhibited deficits in fertility, growth, and locomotion, loss of tdp-1 attenuated defects in several C. elegans models of proteotoxicity. Loss of tdp-1 suppressed defects in transgenic C. elegans expressing TDP-43 or CuZn superoxide dismutase, both of which are associated with proteotoxicity in neurodegenerative diseases. Loss of tdp-1 also reduced defects in mutant animals lacking the heat shock factor HSF-1. Transcriptional profiling demonstrated that the loss of TDP-1 altered expression of genes functioning in RNA processing and protein folding. Furthermore, the absence of tdp-1 extended the life span in C. elegans. The life span extension required a FOXO transcriptional factor DAF-16 but not HSF-1. These results suggest that the C. elegans TDP-1 has a role in the regulation of protein homeostasis and aging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232551      PMCID: PMC3318719          DOI: 10.1074/jbc.M111.311977

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.

Authors:  Iga Wegorzewska; Shaughn Bell; Nigel J Cairns; Timothy M Miller; Robert H Baloh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-15       Impact factor: 11.205

2.  TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing.

Authors:  Jayarama Krishnan Bose; I-Fan Wang; Li Hung; Woan-Yuh Tarn; C-K James Shen
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

3.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.

Authors:  Brian S Johnson; J Michael McCaffery; Susan Lindquist; Aaron D Gitler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

4.  A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues: role for TDP-43 in insulator function.

Authors:  Mayuresh M Abhyankar; Craig Urekar; Prabhakara P Reddi
Journal:  J Biol Chem       Date:  2007-10-11       Impact factor: 5.157

5.  Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.

Authors:  T J Kwiatkowski; D A Bosco; A L Leclerc; E Tamrazian; C R Vanderburg; C Russ; A Davis; J Gilchrist; E J Kasarskis; T Munsat; P Valdmanis; G A Rouleau; B A Hosler; P Cortelli; P J de Jong; Y Yoshinaga; J L Haines; M A Pericak-Vance; J Yan; N Ticozzi; T Siddique; D McKenna-Yasek; P C Sapp; H R Horvitz; J E Landers; R H Brown
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

6.  TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.

Authors:  Brian S Johnson; David Snead; Jonathan J Lee; J Michael McCaffery; James Shorter; Aaron D Gitler
Journal:  J Biol Chem       Date:  2009-05-22       Impact factor: 5.157

Review 7.  Adapting proteostasis for disease intervention.

Authors:  William E Balch; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly
Journal:  Science       Date:  2008-02-15       Impact factor: 63.714

8.  An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans.

Authors:  Jiou Wang; George W Farr; David H Hall; Fei Li; Krystyna Furtak; Lars Dreier; Arthur L Horwich
Journal:  PLoS Genet       Date:  2009-01-23       Impact factor: 5.917

9.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

10.  Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.

Authors:  Caroline Vance; Boris Rogelj; Tibor Hortobágyi; Kurt J De Vos; Agnes Lumi Nishimura; Jemeen Sreedharan; Xun Hu; Bradley Smith; Deborah Ruddy; Paul Wright; Jeban Ganesalingam; Kelly L Williams; Vineeta Tripathi; Safa Al-Saraj; Ammar Al-Chalabi; P Nigel Leigh; Ian P Blair; Garth Nicholson; Jackie de Belleroche; Jean-Marc Gallo; Christopher C Miller; Christopher E Shaw
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

View more
  31 in total

Review 1.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

Review 2.  RNA-binding proteins associated molecular mechanisms of motor neuron degeneration pathogenesis.

Authors:  Anna Y Tang
Journal:  Mol Biotechnol       Date:  2014-09       Impact factor: 2.695

3.  NeuCode Labeling in Nematodes: Proteomic and Phosphoproteomic Impact of Ascaroside Treatment in Caenorhabditis elegans.

Authors:  Timothy W Rhoads; Aman Prasad; Nicholas W Kwiecien; Anna E Merrill; Kelson Zawack; Michael S Westphall; Frank C Schroeder; Judith Kimble; Joshua J Coon
Journal:  Mol Cell Proteomics       Date:  2015-09-21       Impact factor: 5.911

4.  TDP-43 toxicity proceeds via calcium dysregulation and necrosis in aging Caenorhabditis elegans motor neurons.

Authors:  Dina Aggad; Julie Vérièpe; Arnaud Tauffenberger; J Alex Parker
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

Review 5.  TDP-43 in the spectrum of MND-FTLD pathologies.

Authors:  Lanier Heyburn; Charbel E-H Moussa
Journal:  Mol Cell Neurosci       Date:  2017-07-04       Impact factor: 4.314

6.  Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion.

Authors:  Lei-Lei Jiang; Mei-Xia Che; Jian Zhao; Chen-Jie Zhou; Mu-Yun Xie; Hai-Yin Li; Jian-Hua He; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

7.  TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion.

Authors:  Qin Xia; Hongfeng Wang; Zongbing Hao; Cheng Fu; Qingsong Hu; Feng Gao; Haigang Ren; Dong Chen; Junhai Han; Zheng Ying; Guanghui Wang
Journal:  EMBO J       Date:  2015-12-23       Impact factor: 11.598

Review 8.  Does a loss of TDP-43 function cause neurodegeneration?

Authors:  Zuo-Shang Xu
Journal:  Mol Neurodegener       Date:  2012-06-14       Impact factor: 14.195

9.  ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43.

Authors:  Eveline S Arnold; Shuo-Chien Ling; Stephanie C Huelga; Clotilde Lagier-Tourenne; Magdalini Polymenidou; Dara Ditsworth; Holly B Kordasiewicz; Melissa McAlonis-Downes; Oleksandr Platoshyn; Philippe A Parone; Sandrine Da Cruz; Kevin M Clutario; Debbie Swing; Lino Tessarollo; Martin Marsala; Christopher E Shaw; Gene W Yeo; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 10.  Protein aggregation in amyotrophic lateral sclerosis.

Authors:  Anna M Blokhuis; Ewout J N Groen; Max Koppers; Leonard H van den Berg; R Jeroen Pasterkamp
Journal:  Acta Neuropathol       Date:  2013-05-15       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.